2,5-Dioxopyrrolidin-1-yl 3-(2-(prop-2-yn-1-yloxy)ethoxy)propanoate, 96+%, 100mg

2-Amino-4-methoxy-6-methylpyrimidine, 98.0%, 25g

tert-butyl 3-{[(4-methoxyphenyl)methyl]amino}-2-methylpropanoate, 95.0%, 10g

7-Fluorobenzo[d]thiazole-2(3H)-thione, 97%, 5g

Vial de reacción con brida plana, cilíndrico, graduado, con camisa atemperada, pieza de conexión KF, DN 150, 5000 ml, 190 mm, 1 pieza

(4-Aminopyridin-2-yl)dimethylphosphine oxide, 97%, 25mg

2-(5-amino-3-tert-butyl-1H-pyrazol-1-yl)ethan-1-ol, 95.0%, 5g

7-Oxooctanoic acid, 97%, 1g

4-BROMO-N-(4-BROMOPHENYL)-N-PHENYLANILINE, 98.0%, 5g

(2,4-Dichloro-5-propoxyphenyl)boronic acid, 95.0%, 5g

2,5-Dioxopyrrolidin-1-yl 19-(2,5-dioxo-2H-pyrrol-1(5H)-yl)-17-oxo-4,7,10,13-tetraoxa-16-azanonadecan-1-oate, 99%, 250mg

5-nitropyridine-2-thiol, 97.0%, 10g

3-(3-bromophenyl)-3'-chloro-4'-fluoropropiophenone, 97.0%, 1g